Effects of single and multiple doses of dexnafenodone, imipramine and placebo on sleep of young healthy volunteers

Human Psychopharmacology

Volumn 11, Issue 3, 1996, Pages 211-215

  Schulz, H ^a   Legler, U ^b   Jobert, M ^a   Greger, G ^b  

^a PAREXEL INTERNATIONAL   (United States)

^b Knoll AG   (Germany)

Author keywords

antidepressant drugs; dexnafenodone; imipramine; REM sleep; sleep

Indexed keywords

ANTIDEPRESSANT AGENT; DEXNAFENODONE; IMIPRAMINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; HUMAN; HUMAN EXPERIMENT; INSOMNIA; MALE; NORMAL HUMAN; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; SLEEP PATTERN;

EID: 0030011359     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199605)11:3<211::AID-HUP789>3.0.CO;2-T     Document Type: Article

References (14)

1. Gillin, J. C. (1983). Sleep studies in affective illness: Diagnostic, therapeutic and pathophysiological implications. Annals of Psychiatry, 13, 367-384.
2. Gillin, J. C., Wyatt, R. J., Fram, D. and Snyder, F. (1978). The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacology, 59, 267-272.
3. Hartmann, E. (1968). Longitudinal studies of sleep and dream patterns in manic-depressive patients. Archives of General Psychiatry, 19, 117-126.
4. Herrington, R. N. and Lader, M. H. (1981). Anti-depressant drugs. In: Handbook of Biological Psychiatry. Part V. Drug Treatment in Psychiatry - Psychotropic Drugs, van Praag, H. M. (Ed.), Marcel Dekker Inc, New York, pp. 1-72.
5. Höchli, D., Riemann, D., Zulley, J. and Berger, M. (1986). Initial REM sleep suppression by chlomipramine: a prognostic tool for treatment response in patients with a major depressive disorder. Biological Psychiatry, 21, 1217-1220.
6. Knoll AG, Investigator's Brochure LU43706, Ludwigshafen, Germany.
7. Kupfer, D. J., Foster, F. G., Reich, L., Thompson, K. S. and Weiss, B. (1976). EEG sleep changes as predictors in depression. American Journal of Psychiatry, 133, 622-626.
8. McCarley, R. W. (1982). REM sleep and depression common neurobiological control mechanisms. American Journal of Psychiatry, 139, 565-570.
9. McCarley, R. W. and Massaquoi, S. G. (1992). Neurobiological structure of the revised limit cycle reciprocal interaction model of REM cycle control. Journal of Sleep Research, 1, 131-132.
10. Nicholson, A. N., Pascoe, P. A. and Turner, C. (1989). Modulation of sleep by trimipramine in man. European Journal of Clinical Pharmacology, 37(2), 145-150.
11. Rechtschaffen, A. and Kales, A. (Eds) (1968). A Manual of Standardized Terminology Techniques and Scoring System for Sleep Stages of Human Subjects. Public Health Service, US Government Printing Office, Washington DC.
12. Vogel, G. (1975). A review of REM sleep deprivation. Archives of General Psychiatry, 32, 749-761.
13. Ware, J. C., Brown, F. W., Moorad, P. J., Pittard, J. T. and Cobert, B. (1985). Comparison of trimipramine and imipramine in depressed insomniac patients. Sleep Research, 14, 65.
14. Wiegand, M., Berger, M., Zulley, J. and von Zerssen, D. (1986). The effect of trimipramine on sleep in patients with major depressive disorder. Pharmacopsychiatry, 19, 198-199.